EU Pharmaceutical Legislation Revisions: What Are the Implications for Biopharma? Anne Dhulesia Sean Dyson Read more
Executive Insights Life Sciences & Pharma Is Biopharma Doing Enough to Advance Novel Targets? May 15, 2025
Article Life Sciences & Pharma AI and Biopharma: New Solutions Emerging Across the US Value Chain December 6, 2024
Executive Insights Life Sciences & Pharma Refining Gross-to-Net Expectations for Improved Strategic Planning November 4, 2024
Published Articles Sustainability To Meet Decarbonization Targets, Master The Circular Economy July 9, 2024